Fluoxetine: Why This “Oldie” is Still a Goody
Fluoxetine (commonly known by the brand name Prozac) was first approved in the late 1980s. That means it’s a dinosaur medication in psychiatric terms. However new research reveals that this SSRI may still have biological consequences that are much deeper than just mood management.
Two new studies show that fluoxetine may affect brain health, immunological function, and metabolic resilience. This suggests that the drug may have more therapeutic uses than previously thought.
Fluoxetine and Cognition
A systematic study conducted in 2024 examined the possible involvement of fluoxetine in Alzheimer’s disease and cognitive decline (Bougea et al., 2024).
Researchers discovered that fluoxetine may affect many molecular pathways associated with neurodegeneration:
• Neurogenesis—Fluoxetine may help new neurons grow, especially in the hippocampus, which is an area of the brain that is very important for memory.
• Less neuroinflammation: Long-term inflammation is a big reason why Alzheimer’s disease becomes worse. Fluoxetine seems to change how inflammation works in the brain.
• Amyloid-related pathways – Some studies done before fluoxetine was used on people show that it may affect the mechanisms that lead to amyloid plaque buildup.
• Synaptic plasticity – Fluoxetine may facilitate neuronal transmission by augmenting synaptic signaling.
Although this information does not show that fluoxetine is a medication for Alzheimer’s disease, This study suggests possibilities that the medicine may possess neuroprotective qualities that transcend its use in depression treatment.
(Bougea et al., 2024)
Fluoxetine and the Immune System
A research published in Science Advances in 2025 found something even more shocking. Researchers demonstrated that fluoxetine may boost IL-10–dependent metabolic defense mechanisms, which might help keep organisms alive after sepsis (Gallant et al., 2025). IL-10 is an important anti-inflammatory cytokine that controls immune responses and stops inflammation from becoming too bad.
The research revealed that fluoxetine can:
• turn on immune-metabolic pathways
• boost IL-10 signaling
• enhance resilience to intense inflammatory stress
This indicates that fluoxetine may affect immunological resilience and metabolic defense pathways, broadening its significance beyond psychiatry (Gallant et al., 2025).
What This Means for Mental Health
These findings indicate a broader trend in neuroscience and medicine.
Psychiatric treatments are not only “mood drugs.” They interact with a number of biological systems, such as: